Progress in Blood Glucose Monitoring in Patients with Hepatogenic Diabetes

Gu-Hao Cai, Tian-Yi Yuwen, Tian-Pu Wang, Xiang Shi

Article ID: 7229
Vol 37, Issue 4, 2023
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233704.173
Received: 9 May 2023; Accepted: 9 May 2023; Available online: 9 May 2023; Issue release: 9 May 2023

Abstract

Hepatogenic diabetes (HD) is secondary to chronic liver parenchymal damage. The main manifestations of HD are hyperglycemia and impaired glucose tolerance, which is caused due to the destruction of the islet cells of pancreas, resulting in the disruption of glucose metabolism. Liver disease and diabetes mellitus are closely related and influence each other. Liver disease may lead to a rise in blood glucose and hence diabetes, which further affects the recovery and treatment of liver disease. It also promotes the deterioration of the liver to a certain extent, because the relationship between cirrhosis and diabetes is highly significant. However, in clinical practice, it is easy for medical personnel to ignore blood glucose in patients with early liver disease, possibly missing the early diagnosis of HD. Therefore, it is important to monitor the blood glucose in patients with liver disease. In this study, we discuss several mainstream blood glucose monitoring techniques to facilitate further research especially in HD.


Keywords

blood glucose monitoring;cirrhosis;hepatogenic diabetes (HD);insulin


References

Supporting Agencies



Copyright (c) 2023 Gu-Hao Cai, Tian-Yi Yuwen, Tian-Pu Wang, Xiang Shi




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).